IRD Stock Analysis: Buy, Sell, or Hold?
IRD - Opus Genetics, Inc. Common Stock
$2.31
-0.19 (-7.60%)
▼
5d:
-9.77%
30d:
+18.46%
90d:
+16.67%
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
22d
Get Alerted When IRD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IRD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IRD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IRD is currently trading at $2.31, which is considered extended relative to its 30-day fair value range of $1.94 to $2.46.
Technical Outlook: Technically, IRD is in a uptrend. Immediate support is located at $2.03, while resistance sits at $3.05. Short-term momentum is weak, with the stock down 7.6% recently.
Market Sentiment: IRD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.73 (+234.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IRD is in a uptrend. Immediate support is located at $2.03, while resistance sits at $3.05. Short-term momentum is weak, with the stock down 7.6% recently.
Market Sentiment: IRD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.73 (+234.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.94 -
$2.46
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.6%)
- BULLISH: Trading 234.5% below Wall St target ($7.73)
- CAUTION: 5-day price weakness (-9.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.94 -
$2.46
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$2.03
Resistance Level
$3.05
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-5.33
Wall Street Target
$7.73
(+234.5%)
Revenue Growth (YoY)
-20.4%
Last updated: February 02, 2026 2:37 AM ET
Data refreshes hourly during market hours. Next update: 3:37 AM
Data refreshes hourly during market hours. Next update: 3:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
|
MRNA
Moderna Inc |
SELL
27 analysts |
$39 | 59 HOLD |